Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Effects of HRS-8427 on Bupropion and Midazolam in Healthy Subjects
NCT07049107Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jun 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HRS-8427, sponsored by Hengrui. Primary endpoints: Maximum Observed Plasma Concentration at 15 Days, Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration at 15 Days and 2 more. Started Jun 2025; status: completed.
02
Drugs
HRS-8427
Beyond the preview
Go deeper on NCT07049107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07049107.